Crescent Capital BDC, Inc. (“Crescent BDC” or “Company” which may
also be referred to as “we,” “us” or “our”) (NASDAQ: CCAP) today
reported results for the fourth quarter and full year ended
December 31, 2019. For the fourth quarter, net investment income
was $8.3 million, or $0.41 per share, and the net increase in net
assets was $9.2 million, or $0.45 per share. For the year, net
investment income was $31.7 million, or $1.83 per share. Reported
net asset value per share was $19.50 at December 31, 20191 as
compared to $19.48 at September 30, 2019.
Declaration of Regular Dividend for
First Quarter 2020
The Company’s Board of Directors (the “Board”)
has declared a regular cash dividend for the first quarter 2020 of
$0.41 per share, which will be paid on or about April 15, 2020 to
stockholders of record as of the close of business on March 31,
2020.
Acquisition of Alcentra Capital
Corporation
On January 31, 2020, the Company completed its
previously announced acquisition of Alcentra Capital Corporation
(“Alcentra Capital”) (formerly NASDAQ: ABDC). With the closing of
the merger, Crescent BDC began trading on the NASDAQ under the
ticker symbol “CCAP” on February 3, 2020.
Stock Repurchase Program
On March 2, 2020, the Company’s previously
authorized stock repurchase program commenced and will be in effect
through January 31, 2021, unless extended, or until the aggregate
approved repurchase amount has been expended. Crescent BDC may
repurchase up to $20 million in the aggregate of its outstanding
common stock in the open market at any time the shares are traded
below 90% of Crescent BDC’s most recently disclosed combined net
asset value.
Proposed Reduced Asset Coverage
On March 3, 2020, the Company’s Board
recommended that stockholders approve a proposal to reduce the
Company’s required minimum asset coverage ratio applicable to
business development companies under the Investment Company Act of
1940, as amended (the “1940 Act”) from 200% to 150%. The Company
expects to hold its Annual Meeting in May 2020, at which time
stockholders will vote, amongst other items, on this proposal.
In addition, the Board unanimously approved the
application of the modified asset coverage requirements to be
effective one year after such Board approval and as a result, the
Company’s asset coverage requirements for senior securities will be
changed from 200% to 150%, effective March 3, 2021. However, if the
stockholder proposal is passed at the Annual Meeting, the Company
would be subject to the modified asset coverage requirements the
day after the Annual Meeting.
Selected Financial Highlights(Amounts in
millions, except per share amounts)
|
Three Months Ended |
|
Year Ended |
|
12/31/2019 |
|
12/31/2018 |
|
12/31/2019 |
|
12/31/2018 |
Net investment income per share |
$ |
0.41 |
|
$ |
0.47 |
|
|
$ |
1.83 |
|
|
$ |
1.65 |
|
Net realized
and unrealized gain (loss) per share, net of taxes |
$ |
0.04 |
|
$ |
(0.61 |
) |
|
$ |
(0.14 |
) |
|
$ |
(0.89 |
) |
Net increase
in net assets resulting from operations per share |
$ |
0.45 |
|
$ |
(0.14 |
) |
|
$ |
1.69 |
|
|
$ |
0.76 |
|
Dividend
distributions per share |
$ |
0.41 |
|
$ |
0.40 |
|
|
$ |
1.64 |
|
|
$ |
1.47 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
investment income |
$ |
14.7 |
|
$ |
10.5 |
|
|
$ |
53.5 |
|
|
$ |
33.3 |
|
Net
investment income |
$ |
8.3 |
|
$ |
6.0 |
|
|
$ |
31.7 |
|
|
$ |
17.7 |
|
Net increase
in net assets resulting from operations |
$ |
9.2 |
|
$ |
(1.8 |
) |
|
$ |
29.3 |
|
|
$ |
8.1 |
|
______________________________________1 Reported net asset value
per share does not give effect to the combination with Alcentra
Capital Corporation, which occurred on January 31, 2020. |
|
As of December 31, |
|
2019 |
|
|
2018 |
|
Total investments, at fair value |
$ |
726.5 |
|
|
$ |
493.3 |
|
Total
assets |
$ |
747.2 |
|
|
$ |
505.4 |
|
Net asset
value per share |
$ |
19.50 |
|
|
$ |
19.43 |
|
Pro forma
combined net asset value per share 2 |
$ |
19.42 |
|
|
|
n/a |
|
|
|
|
|
|
|
|
|
Weighted
average yield of debt and other income producing securities (at
cost) |
|
8.4% |
|
|
|
9.0% |
|
Percentage
of debt bearing a floating rate at fair value |
|
97.9% |
|
|
|
95.2% |
|
Portfolio & Investment Activity
As of December 31, 2019 and December 31, 2018, the Company had
investments in 98 and 86 portfolio companies with an aggregate fair
value of $726.5 million and $493.3 million, respectively. The
portfolio at fair value was comprised of the following asset
types:
Portfolio Asset Types: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2019 |
|
December 31, 2018 |
($ in millions) |
|
Fair Value |
|
Percentage |
|
Fair Value |
|
Percentage |
Senior secured first lien |
|
$ |
351.3 |
|
|
48.3% |
|
|
$ |
294.4 |
|
|
59.7% |
|
Unitranche
first lien |
|
|
218.3 |
|
|
30.1 |
|
|
|
68.1 |
|
|
13.8 |
|
Unitranche
first lien - last out |
|
|
16.2 |
|
|
2.2 |
|
|
|
16.8 |
|
|
3.4 |
|
Senior
secured second lien |
|
|
58.9 |
|
|
8.1 |
|
|
|
75.8 |
|
|
15.3 |
|
Unsecured
debt |
|
|
7.4 |
|
|
1.0 |
|
|
|
7.2 |
|
|
1.5 |
|
Preferred
stock |
|
|
4.8 |
|
|
0.7 |
|
|
|
2.3 |
|
|
0.5 |
|
Common stock
and other 3 |
|
|
69.6 |
|
|
9.6 |
|
|
|
28.7 |
|
|
5.8 |
|
Total investment |
|
$ |
726.5 |
|
|
100.0% |
|
|
$ |
493.3 |
|
|
100.0% |
|
Fourth Quarter
For the quarter ended December 31, 2019, the
Company invested $80.8 million across 7 new portfolio companies and
23 existing portfolio companies. During this period, the Company
had $48.7 million in aggregate exits, sales and repayments.
For the quarter ended December 31, 2018, the
Company invested $79.1 million across 9 new portfolio companies and
22 existing portfolio companies. During this period, the Company
had $29.0 million in aggregate exits, sales and repayments.
Full Year
For the year ended December 31, 2019, the
Company invested $378.3 million across 32 new portfolio companies
and 41 existing portfolio companies. During this period, the
Company had $145.8 million in aggregate exits, sales and
repayments.
For the year ended December 31, 2018, the
Company invested $291.2 million across 38 new portfolio companies
and 31 existing portfolio companies. During this period, the
Company had $109.7 million in aggregate exits, sales and
repayments.
______________________________________2 Pro
forma combined net asset value per share is based on the unaudited
pro forma condensed consolidated balance sheet as of December 31,
2019 which assumes the Alcentra Capital Corporation acquisition had
been completed as of December 31, 2019. See Form 10-K for further
detail and discussion.3Includes investments in CBDC Senior Loan
Fund, LLC and GACP II LP.
Results of Operations
Fourth Quarter
For the quarters ended December 31, 2019 and
2018, investment income totaled $14.7 million and $10.5 million,
respectively. The increase was primarily driven by an increase in
interest from investments due to an increase in the size of our
portfolio.
For the quarters ended December 31, 2019 and
2018, total net expenses, excluding income and excise tax, totaled
$6.2 million and $4.4 million, respectively. The increase was
primarily driven by higher interest and debt financing costs as the
weighted average debt outstanding increased from $219.4 million for
the quarter ended December 31, 2018 to $324.3 million for the
quarter ended December 31, 2019.
Full Year
For the years ended December 31, 2019 and 2018,
investment income totaled $53.5 million and $33.3 million,
respectively. The increase was primarily driven by an increase in
interest from investments due to an increase in the size of
Crescent BDC’s portfolio.
For the years ended December 31, 2019 and 2018,
total net expenses, excluding income and excise tax, totaled $21.7
million and $15.4 million, respectively. The increase was primarily
driven by higher interest and debt financing costs as the weighted
average debt outstanding increased from $182.3 million for the year
ended December 31, 2018 to $275.9 million for the year ended
December 31, 2019.
Liquidity and Capital Resources
As of December 31, 2019, the Company had $13.4
million in cash and cash equivalents and restricted cash, $44.3
million of uncalled equity commitments and $124.6 million of
undrawn capacity on its revolving credit and special purpose
vehicle asset facilities, subject to borrowing base and other
limitations. The weighted average interest rate of debt outstanding
was 4.4% for the year ended December 31, 2019.
The Company’s ending debt to equity leverage
ratio was 0.80x as of December 31, 2019.
Conference Call
As previously announced, in light of the January
2020 acquisition of Alcentra Capital Corporation, the Company will
not be hosting an earnings conference call to discuss its fourth
quarter and full year 2019 results. Upon the release of its first
quarter 2020 results, Crescent BDC will host an earnings call to
discuss its first quarter of combined results inclusive of the
Alcentra Capital Corporation acquisition.
Supplemental Information
An investor presentation of financial
information is available on the Investor Relations section of
Crescent BDC’s website at www.crescentbdc.com under Events &
Presentations.
About Crescent BDC
Crescent BDC is a business development
company that seeks to maximize the total return of its stockholders
in the form of current income and capital appreciation by providing
capital solutions to middle market companies with sound business
fundamentals and strong growth prospects. Crescent BDC utilizes the
extensive experience, origination capabilities and disciplined
investment process of Crescent Capital Group
LP. Crescent BDC is externally managed by Crescent Cap
Advisors, a subsidiary of Crescent Capital. Crescent BDC has
elected to be regulated as a business development company under the
Investment Company Act of 1940. For more information about Crescent
BDC, visit www.crescentbdc.com. However, the contents of such
website are not and should not be deemed to be incorporated by
reference herein.
About Crescent Capital
Group
Crescent Capital is a global credit investment
manager with approximately $28 billion of assets under management.
For over 25 years, the firm has focused on below investment grade
credit through strategies that invest in marketable and
privately-originated debt securities including senior bank loans,
high yield bonds, as well as private senior, unitranche, and junior
debt securities. Crescent Capital is headquartered in Los
Angeles with offices in New York, Boston, and London and more than
180 employees globally. For more information about Crescent
Capital, visit www.crescentcap.com. However, the contents of such
website are not and should not be deemed to be incorporated by
reference herein.
Contact:
Daniel
McMahondaniel.mcmahon@crescentcap.com
212-364-0149
Forward-Looking Statements
Statements included herein may constitute “forward-looking
statements,” which relate to future events or our future
performance or financial condition. These statements are not
guarantees of future performance, condition or results and involve
a number of risks and uncertainties. Actual results and conditions
may differ materially from those in the forward-looking statements
as a result of a number of factors, including those described from
time to time in our filings with the Securities and Exchange
Commission. Crescent BDC undertakes no duty to update any
forward-looking statements made herein.
Other Information
The information in this press release is summary information
only and should be read in conjunction with Crescent BDC’s annual
report on Form 10-K for the year ended December 31, 2019, which
Crescent BDC filed with the U.S. Securities and Exchange Commission
(the SEC) on March 4, 2020, as well as Crescent BDC’s other reports
filed with the SEC. A copy of Crescent BDC’s annual report on Form
10-K for the year ended December 31, 2019 and Crescent BDC’s other
reports filed with the SEC can be found on Crescent BDC’s website
at www.crescentbdc.com and the SEC’s website at www.sec.gov.
Crescent
Capital BDC, Inc. |
|
Consolidated
Statements of Assets and Liabilities |
|
(Audited) |
|
|
|
|
|
As
of |
|
As
of |
|
|
|
December 31, 2019 |
December 31, 2018 |
Assets |
|
|
|
|
|
|
|
Investments, non-controlled and non-affiliated, at fair value (cost
of $695,094,640 and $500,680,681, respectively) |
|
$ |
692,089,440 |
|
|
$ |
493,341,724 |
|
|
Investments,
controlled, at fair value (cost of $34,000,000 and $0,
respectively) |
|
|
34,441,720 |
|
|
|
— |
|
|
Cash and
cash equivalents |
|
|
3,866,854 |
|
|
|
3,666,607 |
|
|
Cash
denominated in foreign currency (cost of $683,934 and $580,874,
respectively) |
|
|
709,380 |
|
|
|
559,011 |
|
|
Restricted
cash |
|
|
8,850,793 |
|
|
|
6,143,205 |
|
|
Prepaid
expenses and other assets |
|
|
3,045,834 |
|
|
|
20,041 |
|
|
Interest
receivable |
|
|
2,832,257 |
|
|
|
1,334,535 |
|
|
Unrealized
appreciation on foreign currency forward contracts |
|
|
757,687 |
|
|
|
17,406 |
|
|
Deferred tax
asset |
|
|
420,492 |
|
|
|
299,474 |
|
|
Receivable
for investments sold |
|
|
160,191 |
|
|
|
37,427 |
|
|
Total assets |
|
$ |
747,174,648 |
|
|
$ |
505,419,430 |
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
|
Debt (net of
deferred financing costs of $3,431,382 and $1,695,193,
respectively) |
|
$ |
322,010,054 |
|
|
$ |
235,707,992 |
|
|
Distributions payable |
|
|
8,553,549 |
|
|
|
5,343,316 |
|
|
Interest and
other debt financing costs payable |
|
|
3,545,468 |
|
|
|
1,849,983 |
|
|
Accrued
expenses and other liabilities |
|
|
3,232,864 |
|
|
|
440,630 |
|
|
Management
fees payable |
|
|
1,342,685 |
|
|
|
963,009 |
|
|
Deferred tax
liability |
|
|
879,359 |
|
|
|
604,402 |
|
|
Professional
fees payable |
|
|
379,907 |
|
|
|
254,929 |
|
|
Due to
Administrator |
|
|
174,999 |
|
|
|
178,461 |
|
|
Directors’
fees payable |
|
|
73,600 |
|
|
|
62,063 |
|
|
Unrealized
depreciation on foreign currency forward contracts |
|
|
65,361 |
|
|
|
— |
|
|
Payable for
investments purchased |
|
|
— |
|
|
|
299,570 |
|
|
Due to
Advisor |
|
|
— |
|
|
|
136,235 |
|
|
Total liabilities |
|
$ |
340,257,846 |
|
|
$ |
245,840,590 |
|
|
|
|
|
|
|
|
|
|
|
|
Net
Assets |
|
|
|
|
|
|
|
Preferred
stock, par value $0.001 per share (10,000 shares authorized, zero
outstanding, respectively) |
|
$ |
— |
|
|
$ |
— |
|
|
Common
stock, par value $0.001 per share (200,000,000 shares authorized,
20,862,314 and 13,358,289 shares issued and outstanding,
respectively) |
|
|
20,862 |
|
|
|
13,358 |
|
|
Paid-in
capital in excess of par value |
|
|
414,293,389 |
|
|
|
266,023,849 |
|
|
Accumulated
loss |
|
|
(7,397,449 |
) |
|
|
(6,458,367 |
) |
|
Total Net Assets |
|
$ |
406,916,802 |
|
|
$ |
259,578,840 |
|
|
Total Liabilities and Net Assets |
|
$ |
747,174,648 |
|
|
$ |
505,419,430 |
|
|
Net asset
value per share |
|
$ |
19.50 |
|
|
$ |
19.43 |
|
|
|
|
Crescent
Capital BDC, Inc. |
Consolidated
Statements of Operations |
(Audited) |
|
|
|
For the year
ended |
|
For the year
ended |
|
For the year
ended |
|
|
December 31, 2019 |
December 31, 2018 |
December 31, 2017 |
Investment Income: |
|
|
|
|
|
|
|
|
|
|
|
|
From
non-controlled and non-affiliated investments: |
|
|
|
|
|
|
|
|
|
|
|
|
Interest income |
|
$ |
47,139,378 |
|
|
$ |
31,609,324 |
|
|
$ |
21,939,077 |
|
Paid-in-kind interest |
|
|
560,349 |
|
|
|
453,478 |
|
|
|
64,952 |
|
Dividend income |
|
|
2,671,215 |
|
|
|
590,947 |
|
|
|
— |
|
Other income |
|
|
805,821 |
|
|
|
641,375 |
|
|
|
287,648 |
|
From
controlled investments: |
|
|
|
|
|
|
|
|
|
|
|
|
Dividend income |
|
|
2,300,000 |
|
|
|
— |
|
|
|
— |
|
Total investment income |
|
|
53,476,763 |
|
|
|
33,295,124 |
|
|
|
22,291,677 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
Interest and
other debt financing costs |
|
|
13,362,283 |
|
|
|
8,450,514 |
|
|
|
5,302,910 |
|
Management
fees |
|
|
9,197,585 |
|
|
|
5,987,170 |
|
|
|
4,266,057 |
|
Income
incentive fees |
|
|
4,752,421 |
|
|
|
2,742,423 |
|
|
|
1,622,836 |
|
Other
general and administrative expenses |
|
|
2,201,283 |
|
|
|
1,851,252 |
|
|
|
1,639,006 |
|
Professional
fees |
|
|
956,930 |
|
|
|
759,974 |
|
|
|
713,672 |
|
Directors’
fees |
|
|
302,633 |
|
|
|
290,000 |
|
|
|
290,000 |
|
Organization
expenses |
|
|
136,295 |
|
|
|
154,143 |
|
|
|
73,015 |
|
Total expenses |
|
|
30,909,430 |
|
|
|
20,235,476 |
|
|
|
13,907,496 |
|
Management
fee waiver |
|
|
(4,502,149 |
) |
|
|
(2,602,190 |
) |
|
|
(1,548,858 |
) |
Incentive
fee waiver |
|
|
(4,752,421 |
) |
|
|
(2,187,445 |
) |
|
|
— |
|
Net expenses |
|
|
21,654,860 |
|
|
|
15,445,841 |
|
|
|
12,358,638 |
|
Net
investment income before taxes |
|
|
31,821,903 |
|
|
|
17,849,283 |
|
|
|
9,933,039 |
|
Income and
excise taxes |
|
|
139,096 |
|
|
|
121,444 |
|
|
|
25,474 |
|
Net
investment income after taxes |
|
|
31,682,807 |
|
|
|
17,727,839 |
|
|
|
9,907,565 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
realized and unrealized gains (losses) on
investments: |
|
|
|
|
|
|
|
|
|
|
|
|
Net realized
gain/(loss) on: |
|
|
|
|
|
|
|
|
|
|
|
|
Non-controlled and non-affiliated investments |
|
|
(7,075,600 |
) |
|
|
(466,647 |
) |
|
|
(342,979 |
) |
Foreign currency transactions |
|
|
(70,149 |
) |
|
|
(79,234 |
) |
|
|
(2,739 |
) |
Net change
in unrealized appreciation (depreciation) on: |
|
|
|
|
|
|
|
|
|
|
|
|
Non-controlled and non-affiliated investments and foreign currency
translation |
|
|
3,846,085 |
|
|
|
(8,997,011 |
) |
|
|
(289,512 |
) |
Controlled investments |
|
|
441,720 |
|
|
|
— |
|
|
|
— |
|
Foreign currency forward contracts |
|
|
674,920 |
|
|
|
17,406 |
|
|
|
— |
|
Net realized
and unrealized gains (losses) on investments |
|
|
(2,183,024 |
) |
|
|
(9,525,486 |
) |
|
|
(635,230 |
) |
Provision
for taxes on realized gain on investments |
|
|
(67,321 |
) |
|
|
— |
|
|
|
— |
|
Benefit/(Provision) for taxes on unrealized appreciation
(depreciation) on investments |
|
|
(153,939 |
) |
|
|
(87,779 |
) |
|
|
(217,149 |
) |
(Provision) benefit for taxes on realized and unrealized gain/loss
on investments |
|
|
(221,260 |
) |
|
|
(87,779 |
) |
|
|
(217,149 |
) |
Net increase (decrease) in net assets resulting from
operations |
$ |
29,278,523 |
|
|
$ |
8,114,574 |
|
|
$ |
9,055,186 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Per
Common Share Data: |
|
|
|
|
|
|
|
|
|
|
|
|
Net increase
in net assets resulting from operations per share (basic and
diluted): |
|
$ |
1.69 |
|
|
$ |
0.76 |
|
|
$ |
1.20 |
|
Net
investment income per share (basic and diluted): |
|
$ |
1.83 |
|
|
$ |
1.65 |
|
|
$ |
1.31 |
|
Weighted
average shares outstanding (basic and diluted): |
|
|
17,344,640 |
|
|
|
10,719,485 |
|
|
|
7,562,447 |
|
Alcentra Capital (NASDAQ:ABDC)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Alcentra Capital (NASDAQ:ABDC)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025